| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/07/2001 | EP1080069A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| 03/07/2001 | EP1080068A1 Modulators of protein tyrosine phosphatases |
| 03/07/2001 | EP1080066A1 Bioreductive cytotoxic agents |
| 03/07/2001 | EP1080057A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene |
| 03/07/2001 | EP1080055A2 24-hydroxyvitamin d, analogs and uses thereof |
| 03/07/2001 | EP1079875A2 Method and compositions for treatment of cancers |
| 03/07/2001 | EP1079863A1 Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation |
| 03/07/2001 | EP1079856A1 Humanized antibodies that recognize verotoxin ii and cell line producing same |
| 03/07/2001 | EP1079852A1 Composition based on pentoxifylline and anticytokin |
| 03/07/2001 | EP1079851A1 Use of anti-prolactin agents to treat proliferative conditions |
| 03/07/2001 | EP1079847A2 Osteoporosis treatment |
| 03/07/2001 | EP1079843A2 USE OF g(a)1 g(b) INTEGRIN RECEPTOR INHIBITORS AND TGF- g(b)1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE |
| 03/07/2001 | EP1079840A1 Synergistic composition of inulin and an anti-cancer drug for use in the treatment of cancer |
| 03/07/2001 | EP1079839A1 Therapeutic anti-cold agent containing isomalt as an active ingredient |
| 03/07/2001 | EP1079838A1 Edelfosin for the treatment of brain tumours |
| 03/07/2001 | EP1079837A1 Method of inhibiting membrane-type matrix metalloproteinase |
| 03/07/2001 | EP1079836A1 Compositions comprising ethisterone or its derivatives |
| 03/07/2001 | EP1079835A1 Pyrazinone thrombin inhibitors |
| 03/07/2001 | EP1079834A1 Stabile compositions comprising levosimendan and alginic acid |
| 03/07/2001 | EP1079833A1 Cocaine receptor binding ligands |
| 03/07/2001 | EP1079832A1 Use of vitamin pp compounds |
| 03/07/2001 | EP1079831A1 Compositions for the treatment of hiv and other viral infections |
| 03/07/2001 | EP1079830A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE |
| 03/07/2001 | EP1079829A1 Use of benzofuroxan derivatives in treating angina pectoris |
| 03/07/2001 | EP1079828A1 New use |
| 03/07/2001 | EP1079827A2 PHARMACEUTICAL PREPARATIONS FOR REGULATING THE RELEASE OF INSULIN BY INFLUENCING THE $g(b)-CELL OF THE PANCREATIC ISLETS OF LANGERHANS |
| 03/07/2001 | EP1079826A2 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases |
| 03/07/2001 | EP1079825A2 Compounds that inhibit the binding of integrins to their receptors |
| 03/07/2001 | EP1079824A1 Triterpene compositions and methods for use thereof |
| 03/07/2001 | EP1079823A1 Compositions comprising organic mono- or dinitrate for treating impotence |
| 03/07/2001 | EP1079822A1 Composition containing polyacrylate, polyterpene, nitroglycerine and possibly polyvinyl acetate |
| 03/07/2001 | EP1079821A1 Protease inhibitors |
| 03/07/2001 | EP1079820A1 Benzamide therapeutics for the treatment of inflammatory bowel disease |
| 03/07/2001 | EP1079819A1 Hydroxamic acid derivatives as antibacterials |
| 03/07/2001 | EP1079818A1 Novel compositions |
| 03/07/2001 | EP1079817A1 Pharmaceutical composition comprising d-chiro-inositol for improving insulin sensitivity and glucose metabolism |
| 03/07/2001 | EP1079816A2 Pharmaceutical composition for neurotrophic action |
| 03/07/2001 | EP1079815A1 Timed-release transdermal systems containing an active ingredient |
| 03/07/2001 | EP1079813A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/07/2001 | EP1079812A1 Novel particulate formulations |
| 03/07/2001 | EP1079809A1 Enteric coated pharmaceutical composition and method of manufacturing |
| 03/07/2001 | EP1079808A1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 03/07/2001 | EP1079807A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract |
| 03/07/2001 | EP1079806A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear |
| 03/07/2001 | EP1079804A1 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug |
| 03/07/2001 | EP1079802A2 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities |
| 03/07/2001 | EP1079790A2 Broad spectrum microbicidal and spermicidal compositions, devices, and methods |
| 03/07/2001 | EP1079764A1 The treatment of sexual dysfunction in certain patient groups |
| 03/07/2001 | EP1079763A2 Serotonergic 5ht 7? receptor compounds for treating ocular and cns disorders |
| 03/07/2001 | EP0934295B1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |
| 03/07/2001 | EP0847276B1 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 03/07/2001 | EP0840732B1 Substituted benzolactam compounds as substance p antagonists |
| 03/07/2001 | EP0839132B1 Novel process for the production of amorphous [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 03/07/2001 | EP0800384B1 Pharmaceutical tablet formulations for direct compression |
| 03/07/2001 | EP0794770B1 Transdermal preparation containing a loratidine metabolite with antihistaminic activity |
| 03/07/2001 | EP0783505B1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 03/07/2001 | EP0777650B1 Biphenylamide derivatives as 5ht 1d antagonists |
| 03/07/2001 | EP0736015B1 Antiviral 2,4-pyrimidindione derivatives and processes for the preparation thereof |
| 03/07/2001 | EP0734379B1 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof |
| 03/07/2001 | EP0730597B1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them |
| 03/07/2001 | EP0730579B1 Substituted indoles as phosphodiesterase type iv inhibitors |
| 03/07/2001 | EP0729350B1 Hydrophobic preparations |
| 03/07/2001 | EP0641325B1 Retroviral protease inhibitors |
| 03/07/2001 | EP0625969B1 Arylalkoxyphenoxy-imidazoline compounds |
| 03/07/2001 | EP0620736B1 Use of leukemia inhibiting factor (lif) for the treatment of tumours and sarcomas |
| 03/07/2001 | CN1286694A Novel 19-norsteroids substd in position 11 'beta', preparation method and intermediates, application as medicines and pharmaceutical compositions contg. them |
| 03/07/2001 | CN1286693A 11 'beta'-halogen-7 'alpha'-substd estratrienes, method for producing pharmaceutical preparations contg. said 11 'beta'-halogen-7 'alpha'-substd estratrienes and use of same for producing medicaments |
| 03/07/2001 | CN1286692A Substances KF-1040 and process for producing same |
| 03/07/2001 | CN1286690A Compounds useful for inhibition of farnesyl protein transferase |
| 03/07/2001 | CN1286688A Method for preparation of citalopram |
| 03/07/2001 | CN1286687A Method for preparation of citalopram |
| 03/07/2001 | CN1286685A Heterocyclic cytotoxic agents |
| 03/07/2001 | CN1286684A Carboxamide derivs. of pyrrolidine, piperidine and hexahydroazepine for treatment of thrombosis disorders |
| 03/07/2001 | CN1286683A Tetrahydrobenzindole derivs |
| 03/07/2001 | CN1286681A Cytostatic agents |
| 03/07/2001 | CN1286679A Lipid mixtures and their use |
| 03/07/2001 | CN1286633A Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis |
| 03/07/2001 | CN1286632A Use of purine nucleosides for modulating axonal outgrowth of central nervous system neurons |
| 03/07/2001 | CN1286266A Application of low-anticoagulant heparin and its derivatives in preparing medicines for preventing and treating liver fibrosis |
| 03/07/2001 | CN1286258A Purine L-nucleoside, analogs and use thereof |
| 03/07/2001 | CN1286255A Pyridine compounds, their preparation method and pharmaceutical compositions contg them |
| 03/07/2001 | CN1286254A Aromatic amino ether as analgesics |
| 03/07/2001 | CN1286253A Dipolycatechin derivateves and preparing process thereof |
| 03/07/2001 | CN1286251A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1286250A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1286105A Moxiburning medicine for acupoint therapy |
| 03/07/2001 | CN1286093A Quickly-acting Chinese-medicinal ointment for treating burn and scald |
| 03/07/2001 | CN1286087A Nasal drops |
| 03/07/2001 | CN1286086A Application of leflunomide |
| 03/07/2001 | CN1286085A Application of leflunomide |
| 03/07/2001 | CN1286084A Injection for cataract operation and treating glaucoma |
| 03/07/2001 | CN1286083A Micropowdered tanshinone preparation and its microwave aided co-grinding process for preparing it |
| 03/07/2001 | CN1286082A Intelligence-developing oral liquid of amino acids |
| 03/07/2001 | CN1286081A High-concentration super-fine perfluorocarbon emulsion for injection and its preparing process |
| 03/07/2001 | CN1062869C Prednisolone derivs |
| 03/07/2001 | CN1062868C Total esculentoside and treating application to endometriosis |
| 03/07/2001 | CN1062867C Derivs. of 12,13-epoxy-tylosin and processes for mfg. thereof |
| 03/07/2001 | CN1062866C Bryostatin as anticancer active compound |
| 03/07/2001 | CN1062865C Process for production of amidinobenzofuran and amidinobenzothiophen derivs. and salt thereof |
| 03/07/2001 | CN1062861C Triazine derivs., production and use thereof |